Lyora Therapeutics

Seed
lyoratx.com Biotech & Healthcare Providence, United States
Total Funding $2.5M
Latest Round $2.5M Seed
Last Announced Jul 14, 2026
Investors Undisclosed
Decision Makers Profile Active

About Lyora Therapeutics

Lyora Therapeutics develops genetic medicines for inherited retinal diseases that currently have no treatment.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Providence, United States
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website lyoratx.com
Domain Registered Date Nov 18, 2024

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $2,500,000 · Seed

    Pluang

  2. Milestone

    Website domain registered

    lyoratx.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Lyora Therapeutics.

Funding History

1 Round
Seed · Jul 14, 2026
$2,500,000 Pluang

Founders & Leadership

1

Luk Vandenberghe

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts